Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra)

Clin Exp Rheumatol. Jan-Feb 2007;25(1):119.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Female
  • Humans
  • Immunocompromised Host / drug effects*
  • Interleukin 1 Receptor Antagonist Protein / adverse effects*
  • Leishmaniasis, Visceral / immunology*

Substances

  • Anti-Inflammatory Agents
  • Interleukin 1 Receptor Antagonist Protein